Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Gastric antisecretory and pharmacologic properties of N,N-dimethyl-N'-(2-diisopropylaminoethyl)-N-(4,6-dimethyl-2-pyridyl)ur ea (L-634,366).

Torchiana ML, Cook PG, Hanson CA, Wesley CA, Westrick BL, Wiese SR, Risley EA, Williams M.

Arch Int Pharmacodyn Ther. 1986 May;281(1):120-33.

PMID:
2875693
2.

A structurally novel stimulator of guanylate cyclase with long-lasting hypotensive activity in the dog.

Pettibone DJ, Sweet CS, Risley EA, Kennedy T.

Eur J Pharmacol. 1985 Oct 22;116(3):307-12.

PMID:
2866968
3.

Ivermectin interactions with benzodiazepine receptors in rat cortex and cerebellum in vitro.

Williams M, Risley EA.

J Neurochem. 1984 Mar;42(3):745-53.

PMID:
6319606
4.

Synthesis and receptor binding studies relevant to the neuroleptic activities of some 1-methyl-4-piperidylidene-9-substituted-pyrrolo[2,1-b][3]benzazepine derivatives.

Remy DC, Britcher SF, King SW, Anderson PS, Hunt CA, Randall WC, BĂ©langer P, Atkinson JG, Girard Y, Rooney CS, Fuentes JJ, Totaro JA, Robinson JL, Risley EA, Williams M.

J Med Chem. 1983 Jul;26(7):974-80.

PMID:
6134835
5.

Antihypertensive beta-adrenergic blocking agents: N-aralkyl analogues of 2-[3-(tert-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.

McClure DE, Baldwin JJ, Randall WC, Lyon TF, Mensler K, Lundell GF, Raab AW, Gross D, Risley EA, Sweet CS, Williams M.

J Med Chem. 1983 May;26(5):649-57.

PMID:
6132999
6.
7.

Interaction of the benzodiazepine antagonists, CGS 8216 and Ro 15-1788, with central adenosine A-1 receptors.

Williams M, Risley EA.

Arch Int Pharmacodyn Ther. 1982 Nov;260(1):50-3.

PMID:
6299218
9.

Interaction of putative anxiolytic agents with central adenosine receptors.

Williams M, Risley EA, Huff JR.

Can J Physiol Pharmacol. 1981 Aug;59(8):897-900.

PMID:
6117363
11.

High affinity binding of 2-chloroadenosine to rat brain synaptic membranes.

Williams M, Risley EA.

Eur J Pharmacol. 1980 Jun 27;64(4):369-70. No abstract available.

PMID:
7389830
12.

Interactions of taurine and beta-alanine with central nervous system neurotransmitter receptors.

Williams M, Risley EA, Totaro JA.

Life Sci. 1980 Feb 18;26(7):557-60. No abstract available.

PMID:
6245320
13.

Effects of deanol, choline and its metabolites on binding of [3H]quinuclidinyl benzilate to rat brain membranes.

Haubrich DR, Risley EA, Williams M.

Biochem Pharmacol. 1979 Dec 15;28(24):3673-4. No abstract available.

PMID:
533566
14.

Synthesis, assignment of absolute configuration, and receptor binding studies relevant to the neuroleptic activities of a series of chiral 3-substituted cyproheptadine atropisomers.

Randall WC, Anderson PS, Cresson EL, Hunt CA, Lyon TF, Rittle KE, Remy DC, Springer JP, Hirshfield JM, Hoogsteen K, Williams M, Risley EA, Totaro JA.

J Med Chem. 1979 Oct;22(10):1222-30. No abstract available.

PMID:
41950
15.
16.
17.

2-(Substituted phenyl)oxazolo[4,5-b]pyridines and 2-(substituted phenyl)oxazolo[5,4-b]pyridines as nonacidic antiinflammatory agents.

Clark RL, Pessolano AA, Witzel B, Lanza T, Shen TY, Van Arman CG, Risley EA.

J Med Chem. 1978 Nov;21(11):1158-62.

PMID:
102794
18.

Identification of the biologically active form of sulindac.

Duggan DE, Hooke KF, Risley EA, Shen TY, Arman CG.

J Pharmacol Exp Ther. 1977 Apr;201(1):8-13.

PMID:
850147
19.

Pharmacology and toxicology of diflunisal.

Stone CA, Van Arman CG, Lotti VJ, Minsker DH, Risley EA, Bagdon WJ, Bokelman DL, Jensen RD, Mendlowski B, Tate CL, Peck HM, Zwickley RE, McKinney SE.

Br J Clin Pharmacol. 1977 Feb;4 Suppl 1:19S-29S. No abstract available.

20.

Interactions of aspirin, indomethacin and other drugs in adjuvant-induced arthritis in the rat.

Van Arman CG, Nuss GW, Risley EA.

J Pharmacol Exp Ther. 1973 Nov;187(2):400-14. No abstract available.

PMID:
4748556
21.

Inhibitory effects of indomethacin, aspirin and certain other drugs on inflammations induced in rat and dog by carrageenan, sodium urate and ellagic acid.

van Arman CG, Carlson RP, Risley EA, Thomas RH, Nuss GW.

J Pharmacol Exp Ther. 1970 Nov;175(2):459-68. No abstract available.

PMID:
5481710
22.

Antiinflammatory activity of indomethacin and plasma corticosterone in rats.

Winter CA, Risley EA, Silber RH.

J Pharmacol Exp Ther. 1968 Jul;162(1):196-201. No abstract available.

PMID:
5656598
23.

[On the pharmacology of 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole acetic acid, a new antiphlogistic agent].

Winter CA, Risley EA.

Arzneimittelforschung. 1965 Apr;15(4):427-9. German. No abstract available.

PMID:
5897986
24.

ANTI-INFLAMMATORY AND ANTIPYRETIC ACTIVITIES OF INDOMETHACIN, 1-(P-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOLE-3-ACETIC ACID.

WINTER CA, RISLEY EA, NUSS GW.

J Pharmacol Exp Ther. 1963 Sep;141:369-76. No abstract available.

PMID:
14064201
25.

Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs.

WINTER CA, RISLEY EA, NUSS GW.

Proc Soc Exp Biol Med. 1962 Dec;111:544-7. No abstract available.

PMID:
14001233
26.

Preparation and properties of purified antisecretory substance; urogastrone.

HUFF JW, RISLEY EA, BARNES RH.

Arch Biochem. 1950 Jan;25(1):133-40. No abstract available.

PMID:
15401222
27.

Aminoaciduria in progressive muscular dystrophy.

AMES SR, RISLEY EA.

Proc Soc Exp Biol Med. 1948 May;68(1):131-5. No abstract available.

PMID:
18863698
28.

Adrenal cortical activity in urine of horses.

RISLEY EA, SCHULTZ AB, et al.

Proc Soc Exp Biol Med. 1947 Nov;66(2):412-4. No abstract available.

PMID:
18921775
29.

The use of the Shay rat in studying anti-ulcer substances.

RISLEY EA, RAYMOND WB, BARNES RH.

Am J Physiol. 1947 Oct 1;150(4):754-9. No abstract available.

PMID:
20268854
30.

The use of the Shay rat in studying anti-ulcer substances.

RISLEY EA, RAYMOND WB, BARNES RH.

Fed Proc. 1947;6(1 Pt 2):285. No abstract available.

PMID:
20343428

Supplemental Content

Loading ...
Support Center